- Home
- NRXP vs JMM Comparison
NRXP vs JMM Comparison
Compare NRXP & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- JMM
- Stock Information
- Founded
- NRXP 2015
- JMM 1988
- Country
- NRXP United States
- JMM United States
- Employees
- NRXP N/A
- JMM N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- JMM Trusts Except Educational Religious and Charitable
- Sector
- NRXP Health Care
- JMM Finance
- Exchange
- NRXP Nasdaq
- JMM Nasdaq
- Market Cap
- NRXP 58.5M
- JMM 59.8M
- IPO Year
- NRXP N/A
- JMM N/A
- Fundamental
- Price
- NRXP $3.05
- JMM $6.39
- Analyst Decision
- NRXP Strong Buy
- JMM
- Analyst Count
- NRXP 5
- JMM 0
- Target Price
- NRXP $31.40
- JMM N/A
- AVG Volume (30 Days)
- NRXP 498.6K
- JMM 16.1K
- Earning Date
- NRXP 11-13-2025
- JMM 01-01-0001
- Dividend Yield
- NRXP N/A
- JMM 5.44%
- EPS Growth
- NRXP N/A
- JMM N/A
- EPS
- NRXP N/A
- JMM N/A
- Revenue
- NRXP N/A
- JMM N/A
- Revenue This Year
- NRXP N/A
- JMM N/A
- Revenue Next Year
- NRXP $231.16
- JMM N/A
- P/E Ratio
- NRXP N/A
- JMM N/A
- Revenue Growth
- NRXP N/A
- JMM N/A
- 52 Week Low
- NRXP $1.10
- JMM $5.29
- 52 Week High
- NRXP $6.01
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- NRXP 58.85
- JMM 53.91
- Support Level
- NRXP $2.91
- JMM $6.29
- Resistance Level
- NRXP $3.18
- JMM $6.49
- Average True Range (ATR)
- NRXP 0.24
- JMM 0.10
- MACD
- NRXP 0.04
- JMM 0.00
- Stochastic Oscillator
- NRXP 87.19
- JMM 43.48
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.